
Ulrich Jorde, MD, discusses the Doraya device’s positive results in the DORAYA-HF feasibility study and Revamp Medical’s plans for a pivotal trial in early 2027.

Ulrich Jorde, MD, is a professor in the department of medicine at Albert Einstein College of Medicine and Montefiore Einstein.